Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Klotho Neurosciences ( (KLTO) ) just unveiled an announcement.
On June 10, 2025, Klotho Neurosciences amended its April 2022 Public Warrant to temporarily reduce the exercise price from $3.49 to $1.35, effective until June 20, 2025. This strategic move aims to incentivize warrant holders to exercise their options within the specified period. Additionally, the company corrected a previous report regarding a stock purchase agreement on June 5, 2025, clarifying that 6,250,000 shares were sold for $500,000, underlining the transaction’s compliance with the Securities Act of 1933.
More about Klotho Neurosciences
Klotho Neurosciences, Inc. operates in the biotechnology industry, focusing on developing innovative solutions for neurological disorders. The company engages in research and development of treatments aimed at improving cognitive function and overall brain health.
Average Trading Volume: 34,461,521
Technical Sentiment Signal: Hold
Current Market Cap: $65.31M
For an in-depth examination of KLTO stock, go to TipRanks’ Stock Analysis page.